Loading
Life sciences · Journal article
Academic Journal of Health Sciences · October 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Normal body mass index (BMI) does not necessarily indicate normal adiposity, and individuals with normal-weight obesity (NWO) may exhibit cardiometabolic abnormalities that remain undetected by BMI-based classification. We examined the cardiometabolic phenotype associated with NWO among adults with normal BMI, with particular attention to sex-related heterogeneity and the discriminatory ability of simple anthropometric measures. Methods: This cross-sectional study included 44,939 Spanish healthcare workers. NWO was defined as BMI 18.5–24.9 kg/m² combined with high or very high body-fat percentage according to sex- and age-specific classification. The primary analytical sample comprised 19,824 participants with normal BMI and either normal adiposity (n=19,040) or NWO (n=784). Cardiometabolic characteristics included glycaemic, lipid, blood-pressure, insulin-resistance-related, and metabolic-syndrome measures. Multivariable logistic regression was used to examine associations between NWO and cardiometabolic abnormalities, including NWO × sex interactions. Receiver operating characteristic analyses evaluated the ability of BMI, waist circumference, and waist-to-height ratio (WHtR) to discriminate NWO. Results: NWO was present in 3.10% (95% confidence interval [CI], 2.89–3.32%) of participants with normal BMI and was more prevalent in men than women (5.43% vs. 2.35%). Compared with normal adiposity, NWO was characterized by greater central adiposity, higher fasting glucose and insulin-resistance-related indices, lower HDL-C, and a more atherogenic lipid profile. At least one abnormal cardiometabolic domain was present in 53.1% of participants with NWO versus 29.2% with normal adiposity. After multivariable adjustment, NWO was associated with ≥1 abnormal domain (adjusted odds ratio [aOR] 2.24; 95% CI, 1.93–2.60), ≥2 abnormal domains (aOR 1.76; 95% CI, 1.36–2.29), elevated triglyceride-glucose index (aOR 3.28; 95% CI, 2.61–4.11), elevated low-density/high-density lipoprotein cholesterol ratio (aOR 3.45; 95% CI, 2.87–4.15), and elevated triglyceride/high-density lipoprotein cholesterol ratio (aOR 2.72; 95% CI, 2.18–3.38). Several associations differed by sex. In receiver operating characteristic (ROC) analyses, waist circumference showed the highest discrimination overall (area under the curve [AUC] 0.776; 95% CI, 0.756–0.795) and among men (AUC 0.836; 95% CI, 0.812–0.858), whereas BMI showed the highest discrimination among women (AUC 0.757; 95% CI, 0.733–0.780). Conclusions: Among Spanish healthcare workers with normal BMI, NWO identified a subgroup with greater concurrent cardiometabolic abnormality burden, particularly involving glycaemic, insulin-resistance-related, and atherogenic characteristics. Associations and anthropometric discrimination differed by sex, highlighting heterogeneity within the conventional normal-BMI category. Prospective studies are needed to determine the prognostic relevance of these phenotypes.